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Background: Percutaneous left atrial appendage (LAA) closure has recently emerged as a new therapeutic option for stroke prevention in 
atrial fibrillation patients at high risk of embolic events, who are not candidates for anticoagulation therapy. The LARIAT© Suture Delivery Device 
(SentreHeart, Redwood, CA, USA) is an FDA approved method of obtaining such closure. The effect of LAA suture on B-type natriuretic peptide (BNP) 
release or cardiac biomarker levels suggestive of LAA tissue necrosis, is not known.
methods: From June 2012 to October 2012, ten patients underwent percutaneous LAA suture with the LARIAT device at our institution. Cardiac 
Troponin I (cTNI), B-type Natriuretic Peptide (BNP), as well as Creatinine Kinase-MB (CK-MB) were assessed pre and post procedure.
results: Of the 10 patients reviewed, ten had a complete set of pre and post-procedural values for cTNI, four had CK-MB levels, and 4 had BNP 
levels. Compared to baseline cTNI (median= 0.04 ± 0.13 ng/ml), there was an increase in post-procedural levels (median= 1.54 ± 0.88 ng/ml) 
with a median time to peak of 26.5 ± 10 hours post-procedure. An increase was also noted in CK-MB levels (baseline= 2.2 ± 1.47 ng/ml vs post-
procedure= 4.6 ± 3.2 ng/ml) with a median time to peak of 17 ± 10 hours. Similarly, BNP levels increased from a median baseline of 74.5 ± 544 
pg/ml to 242 ± 614 pg/ml, with a median time to peak of 6.5 ± 8 hours post-procedure. There was no evidence of peri-procedural coronary events 
in any of the patients, ECG changes or new wall motion abnormalities by echocardiogram.
conclusion: Percutaneous left atrial appendage suture with the LARIAT© device appears to be associated with an increase in the levels of cTNI, 
CK-MB, and BNP in the acute phase (24 to 48 hours). We suspect that the post-procedural increase in injury biomarkers likely reflect LAA tissue 
necrosis and not a peri-procedural coronary event. The clinical significance of these findings is unknown. Further studies in a larger number of 
patients with longer follow up are needed.
